Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Alivira Animal Health has gained WHO-Geneva approval for the manufacture of praziquantel-based anthelmintics at its facility in Vizag.
Virbac has seen its share price rise to its highest level since March 2015.
Czech Republic-based Bioveta has posted 10% organic sales growth in the first nine months of 2019.
Indian firm Hester Biosciences claims the current financial predicament faced by the United Nations (UN) will not have a knock-on effect on its Nepalese business.
Boehringer Ingelheim Animal Health has completed the expansion of its R&D and manufacturing plant in Athens, Georgia.
Royal DSM has appointed Carlos Saviani to the role of head of global sustainability for animal nutrition and health.
US firm ImmuCell has seen its share price fall to its lowest value since December 2014.
Canadian firm Avivagen has added to its Asian network of sales by achieving its first order from Taiwan for its OxC-beta Livestock feed additive.
Chinese animal health firms were not unscathed by African swine fever (ASF) in 2018 but the disease arrived too late in the calendar year for it to seriously trouble companies' full-year results. However, pressure started to emerge in the first-half of 2019, Animal Pharm correspondent Louis Harkell reports.
The European Medicines Agency (EMA) is reviewing its organizational structure following the impact of Brexit on its fourth quarter and workforce.
Elanco aims to make $12 million in savings by 2020 through an additional set of restructuring plans.
Alltech has expanded its mycotoxin testing capabilities at its laboratory in Dunboyne, Ireland.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.